Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers.
about
p73 as a pharmaceutical target for cancer therapyHigh-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes.Role of p73 Dinucleotide Polymorphism in Prostate Cancer and p73 Protein Isoform Balance.TP53 family members and human cancers.The type III TGF-beta receptor suppresses breast cancer progressionRole of ERRF, a novel ER-related nuclear factor, in the growth control of ER-positive human breast cancer cellsMDM2 mediates p73 ubiquitination: a new molecular mechanism for suppression of p73 function1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma modelAssociation between the p73 gene G4C14-to-A4T14 single nucleotide polymorphism and risk of cervical cancer by high resolution melting and PCR with confronting two-pair primers in a Chinese population.Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancerTranscriptional inactivation of TP73 expression in oligodendroglial tumors.Down-regulation of CD3zeta is a breast cancer biomarker associated with immune suppression.p53 Activity Dominates That of p73 upon Mdm4 Loss in Development and Tumorigenesis.P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?WWP2-WWP1 ubiquitin ligase complex coordinated by PPM1G maintains the balance between cellular p73 and ΔNp73 levels.Polymorphisms ofp53Arg72Pro,p73G4C14-to-A4T14 at Exon 2 andp21Ser31Arg and the risk of non-Hodgkin's Lymphoma in Japanese
P2860
Q28611414-131867BB-1CD3-49E0-A803-AD475EAEFBBEQ33826097-18F1DA1D-9DE8-4237-A866-1EC1F0A263FAQ33942673-C6AEC9F9-D131-4336-9B2D-F982C3BBC4B2Q35078717-54ABB708-D762-42FC-B0AC-0571D93B645EQ35191593-65A1F598-A0E2-45A2-B5AA-89F5C5677D7CQ35952045-5CC58522-A6BF-4E45-A03A-557C1A95EAA6Q36356371-20796D80-B998-4D9E-A9A0-19974F6AB21CQ36982956-F984365B-B615-469B-9E6A-324064A68B69Q37002689-80816DF3-7F7C-4BD5-9F0E-2647EF138856Q37355456-53C8653F-F545-4F09-9A73-0C54FF25A95FQ38290743-DBCC60F7-714F-4FD8-9CB2-D627E357FC4DQ39649670-9B8A1355-0B1B-4C25-8573-99AC45C04C19Q40363516-271C3464-1DC6-409D-8E4B-698D8DCF0527Q42509601-8DF9D3CE-E6ED-4AD2-9887-E96BD7F6CC3EQ42932497-55B908F8-50C7-49C6-B673-79BC5BFE6229Q57918995-83873FCB-C15E-49A8-8EE0-EF8D7F84DAAF
P2860
Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Loss of heterozygosity, allele ...... n inflammatory breast cancers.
@en
Loss of heterozygosity, allele ...... n inflammatory breast cancers.
@nl
type
label
Loss of heterozygosity, allele ...... n inflammatory breast cancers.
@en
Loss of heterozygosity, allele ...... n inflammatory breast cancers.
@nl
prefLabel
Loss of heterozygosity, allele ...... n inflammatory breast cancers.
@en
Loss of heterozygosity, allele ...... n inflammatory breast cancers.
@nl
P2093
P2860
P356
P1433
P1476
Loss of heterozygosity, allele ...... n inflammatory breast cancers.
@en
P2093
J C Ahomadegbe
M C Mathieu
M Spielmann
M Vayssade
P2860
P2888
P304
P356
10.1038/SJ.ONC.1203914
P407
P50
P577
2000-11-01T00:00:00Z
P5875
P6179
1019702481